Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nanopore Sequencing for Detecting Bacteria in Bile and Preventing Surgical Site Infections in Patients Undergoing Surgery for Benign or Malignant Pancreatic Tumors

NCT05523154 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05523154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05523154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nanopore Sequencing for Detecting Bacteria in Bile and Preventing Surgical Site Infections in Patients Undergoing Surgery for Benign or Malignant Pancreatic Tumors
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Terminated
Start date
January 19, 2023
Completion date
November 27, 2023
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign pancreatic neoplasm, malignant pancreatic neoplasm